ANEBOTCPharmaceutical PreparationsFiscal year ends June 30
Anebulo Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026
$0.00+0.00 (+75.00%)
Close on Oct 19, 2026
- Market cap
- $28.76K
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Anebulo Pharmaceuticals from other investors
No posts about ANEB yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.